Blog Archives - Page 18 of 77 - NFCR

Blog

Natural Killer (NK) Cell-based Treatment Demonstrates Its Potential to Become an Effective Novel Cancer Therapy

Natural Killer (NK) cells are specialized lymphocytes that play critical roles in the immune response against abnormal cells, including all kinds of cancer cells. Different from T cells that need to be pre-activated by antigen-presenting cells before gaining the killing power, NK cells can quickly respond to a wide variety…...

Read more

New Brain Scan Technology Can Improve Tumor Removal

Any illness or disease that impacts the brain is highly complex. None more so than brain tumors, which affect over 20,000 Americans each year. While surgeons have become more advanced in the removal of brain tumors, experts continue to face extreme challenges in ensuring all cancerous tissues are removed during surgery. That…...

Read more

10 Ways to Keep Your Kids Active

Did you know that only 1 in 4 children gets the recommended 60 minutes of physical activity per day? While sitting at a desk studying can certainly boost a student’s grade point average, the alarming increase of a sedentary lifestyle amongst children can increase their risk of cancer.  The National Health and Nutrition…...

Read more

Melanoma 101: What You Need to Know

Skin cancer diagnoses are growing at an alarming rate.  In fact, over the past three decades, more people have been diagnosed with some form of skin cancer than all other cancers combined. Melanoma, an aggressive form of skin cancer, is the deadliest type.  Many cases of melanoma can be prevented. To protect…...

Read more

Interview with NFCR CEO Sujuan Ba Featured in BioBuzz—a Popular Regional Industry News Source

5 Questions with Dr. Sujuan Ba, President & CEO of the National Foundation for Cancer Research “5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. This…...

Read more

Phase II Clinical Trials May Be on the Way for Ovarian Cancer

Dubbed one of the notorious ‘silent killers’, ovarian cancer claims the lives of approximately 14,000 American women each year. Tragically, all women are at risk and early detection and sustainable treatment have proved to be difficult. However, a recent study provides new hope in the realm of ovarian cancer treatment.…...

Read more

5 Facts about Esophageal Cancer

Aside from the fact that it’s a tricky word to say, few people know much else about Esophageal Cancer—a relatively rare cancer. Esophageal cancer is cancer that impacts the 10-inch-long tube that connects the mouth to the stomach. That important track is vital to survive, and used daily, but esophageal…...

Read more